Mednet Logo
HomeNeurology
Neurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

What are your recommendations for screening for sleep disorders in patients with IDD?

1 Answers

Mednet Member
Mednet Member
Neurology · Virtua Health

Sleep disorders are very common for people with IDD. One consideration, in particular, is in patients with Down Syndrome because of the shape of their mouth and large tongue. They have a very high rate of sleep apnea, obstructive sleep apnea in particular, which can be seen even in children. You wo...

Does global brain atrophy increase risk for intracranial bleed after fall in older adults?

1 Answers

Mednet Member
Mednet Member
Neurology · Vanderbilt University Medical Center

It depends on the location of the hemorrhage. Subdural bleeding/hematoma is much more likely in elderly people with brain atrophy and a fall. Epidural hemorrhage is much more common in young patients. Intracerebral hemorrhage is more related to risk factors such as hypertension in middle age and amy...

What MRI findings would you consider compatible with an acute seizure or seizures?

1
1 Answers

Mednet Member
Mednet Member
Neurology · Memorial Sloan Kettering Cancer Center

Frequent seizures and status epilepticus can result in reversible neuroimaging findings such as cortical enhancement, DWI cortical ribboning, and decreased attenuation on CT. Imaging findings can be resolved with control of seizures.Hormigo et al., PMID 15023812Kramer et al., PMID 3653056Riela et al...

How do you determine if generic vs. brand formulation of a DMT is the probable cause of worsening multiple sclerosis disease activity?

1 Answers

Mednet Member
Mednet Member
Neurology · Cleveland Clinic

I based this on the timing of the switch to generic formulations and the duration of stability on brand formulation. For example, if a patient has been on brand DMT with stability for 5 years, then recently changed to generic with disease activity within the first year, I would consider that the gen...

Would you recommend muscle or nerve biopsy in a patient with amyoplasia congenita?

1 Answers

Mednet Member
Mednet Member
Neurology · McMaster University

No, I would not for at least 2 reasons. The probability of getting a quality sample is very low, and it is most likely that no muscle would be obtained as the name of the disorder implies (amyoplasia). Furthermore, the likelihood of finding a genetic cause for this is VERY low. In fact, in using WES...

What is your approach to Tardive Dyskinesia when VMAT2 inhibitors are ineffective or unaffordable?

2
4 Answers

Mednet Member
Mednet Member
Neurology · University of Pittsburgh School of Medicine

In established cases of tardive dyskinesia, in which withdrawal-emergent dyskinesia has been ruled out, and dyskinesia has persisted despite a sufficient washout interval after removal of the offending agent, VAM2 inhibitors such as valbenazine and deutetrabenazine are used for pharmacotherapy. If t...

How will your approach to screening and diagnosis of early dementia change given newly available therapies for early Alzheimer's disease?

1
5 Answers

Mednet Member
Mednet Member
Neurology · UCSF

As it stands, it is not recommended to screen asymptomatic patients for the proteins seen in Alzheimer’s disease outside of clinical trials (i.e., AHEAD 3-45). However, with the emergence of new treatment options in the clinic, I foresee an influx of patients with cognitive symptoms who need a preci...

How do you approach a patient with both a resting and action tremor, suggestive of PD and essential tremor together?

1 Answers

Mednet Member
Mednet Member
Neurology · Emory Clinic

This is a wonderful question. To answer this question, we first have to look at the underlying etiology that leads to action tremor in PD. The hallmark of Parkinson's Disease (PD) is rest tremor, and about 75% of patients with PD have rest tremor at some point in their disease course (typically more...

Where in your treatment approach to fibromyalgia will you recommend sublingual cyclobenzaprine? 

3 Answers

Mednet Member
Mednet Member
Rheumatology · The University of Michigan

The choice of medication for any given patient is based on a lot of factors and, realistically, is often highly dependent on affordability and insurance coverage across different pharmacy plans. Despite other FDA-approved options, oral cyclobenzaprine is usually the medication I reach for first with...

How does the presence of 1-3 microbleeds on MRI influence your choice of anti-amyloid therapies for patients with MCI or mild AD?

2
2 Answers

Mednet Member
Mednet Member
Neurology · Vanderbilt University Medical Center

1-3 microbleeds is a small number, and the question does not specify that to be suspicious for amyloid angiopathy, the microbleeds should be cortical/subcortical, not deep (as seen in hypertensive individuals). This number, assuming that there are no signs of a larger hemorrhage nor superficial side...